Signing of definitive purchase agreement represents critical next step in completing previously announced acquisition SARASOTA, Fla. and INDIANAPOLIS, Dec. 17, 2025 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it has signed a definitive purchase agreement to acquire Family Beginnings, P.C., a respected fertility clinic serving patients across Indiana and the broader Midwest. The execution of the purchase agreement marks a critical milestone following the Company’s November 27, 2025 announcement of its intent to acquire Family Beginnings, and represents the next key step toward completing the transaction and advancing INVO’s...

The nation’s largest Latino business network will integrate its global event and research capabilities into The Alumni Society Network San Diego, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) — The National Association of Hispanic Real Estate Professionals® (NAHREP®), with its 58,000 members and 100 chapters, announced that it has acquired The Alumni Society (TAS), a member organization of 5,700 business leaders who graduated from Ivy League and other elite universities, from Guerrero Media, publisher of Hispanic Executive. NAHREP plans to convert TAS into a non-profit organization, appoint a board of senior-level members, and operate it as an independent organization. TAS will now join NAHREP’s family of affiliated groups, which includes the National Hispanic Construction Alliance, AVANCE Sports, and the Hispanic Wealth Project. “The focus...

LAS VEGAS, Dec. 17, 2025 (GLOBE NEWSWIRE) — Renewal Fuels, Inc. (OTC: RNWF) (“RNWF” or the “Company”) and Kepler Fusion Technologies Inc. (“Kepler”) today announced the execution of a definitive merger transaction pursuant to which Kepler will combine with and become a wholly owned subsidiary of RNWF. The transaction represents a transformative strategic milestone for both companies and is intended to establish a publicly traded advanced energy infrastructure platform centered on Kepler’s proprietary fusion technology. The Company expects to pursue long-term value creation through scalable deployment of next-generation fusion energy systems within a public-company structure designed to support disciplined grow. Upon closing, Kepler will operate as a wholly owned subsidiary of RNWF, with Kepler equity holders receiving common stock...

Following closing, combined company plans to progress Yarrow’s lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating hormone receptor (“TSHR”) antibody for Graves’ disease (“GD”) and thyroid eye disease (“TED”) Yarrow Bioscience is the seventh biotechnology company founded by RTW Investments and plans to advance in-licensed asset YB-101 (also known as GS-098) into a U.S.-based Phase 1b/2b trial in patients with GD in the first half of 2026; a Phase 1 trial in TED is being conducted in China by partner Changchun GeneScience Pharmaceutical Co., Ltd (“GenSci”) Pre-closing private financings totaling approximately $200 million expected to fund operations into 2028 Companies to hold conference call on December 17, 2025 at 8:30AM EDTNEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE)...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — E.F. Hutton is proud to have served as an Exclusive M&A Advisor in the recently completed merger between Apimeds Pharmaceuticals US Inc. (NYSE American: APUS) and Mindwave Innovations Inc. The merger brings together a biotech development platform with an AI-powered digital treasury infrastructure supported by a $100 million PIPE commitment, for which E.F. Hutton acted as Placement Agent. E.F. Hutton’s involvement underscores its commitment to advancing the combined company’s strategic growth across late-stage biotech development and institutional Digital Asset Treasury Solutions. E.F. Hutton worked closely with both companies to shape the transaction framework, coordinate investor participation, and guide the capital raise through a complex diligence and negotiation process. The merger...

VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) — Eldorado Gold Corporation (TSX: ELD, NYSE: EGO) (“Eldorado” or the “Company”) Eldorado Gold Corporation (“Eldorado”) advises that effective December 17, 2025, it has acquired ownership of 14,868,200 common shares (“Shares”) of Amex Exploration Inc. (“Amex”) at a price per Share of C$4.00, for total consideration of C$59,472,800, pursuant to a private agreement with a third party (the “Share Acquisition”). Prior to the Share Acquisition, Eldorado beneficially owned and controlled 23,758,130 common shares of the Company and 207,000 common share purchase warrants, each warrant entitling the holder to acquire one Share (the “Warrants”), representing approximately 16.77% of the outstanding common shares on a non-diluted basis and approximately 16.89% on a partially...

Strategic acquisition will strengthen ABM’s position in fast-growing semiconductor and technology manufacturing markets NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a major provider of integrated facility, infrastructure, and technical solutions, today announced a definitive agreement to acquire WGNSTAR, a leading provider of managed workforce solutions and equipment support services for the semiconductor and high-technology industries, in a cash transaction valued at approximately $275 million. WGNSTAR operates across the U.S. and in Ireland, delivering technical and operational solutions through a highly skilled workforce of more than 1,300 employees and long-standing client partnerships, many exceeding two decades. WGNSTAR generates over half of its revenue from integrated workforce programs, delivering highly...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Acquired assets further optimize Vireo’s operating footprint in Colorado with addition of 17 dispensaries Transaction expands Vireo’s leadership position in the Colorado retail market with 41 total dispensaries Parties also enter into Management Services Agreement through closing which is expected in 1H’26 MINNEAPOLIS, Dec. 16, 2025 (GLOBE NEWSWIRE) — Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it and its subsidiary Vireo Health, Inc. have entered into an Asset Purchase Agreement (“APA”) to acquire certain retail assets and properties of PharmaCann Inc. in the State of Colorado. The transaction will expand Vireo’s position in Colorado’s adult-use retail market to 41 total active dispensaries, and is subject to satisfaction of closing conditions and state and local regulatory...